JBT-101

· Corbus Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for JBT-101, covering 2018-10-02 to 2023-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis [Phase 2]